Development of Small Molecule Inhibitors Targeting HSP90 C-terminal Dimerization in BCR-ABL1 positive Leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Düsseldorf, Heinrich-Heine-Universität, Dissertation, 2023
- Schlagwort
-
Hitzeschock-Proteine
- Ereignis
-
Veröffentlichung
- (wo)
-
Düsseldorf
- (wer)
-
Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
- (wann)
-
2025
- Urheber
- Beteiligte Personen und Organisationen
-
Kurz, Thomas
Hauer, Julia
- URN
-
urn:nbn:de:hbz:061-20250206-095055-9
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dienstbier, Niklas
- Kurz, Thomas
- Hauer, Julia
- Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
Entstanden
- 2025
Ähnliche Objekte (12)
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells
Genomische BCR-ABL1-Bruchpunkte bei kindlichen Leukämien
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms
Decrypting the role of HSP90α and β isoforms in BCR-ABL1+ leukemia and Characterization of Small Molecule HSP90 Inhibitors and Degraders
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K
The role of proteostasis in BCR-ABL1-positive acute lymphoblastic leukemia
Pre-B cell receptor signaling prevents malignant transformation by BCR-ABL1
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells
Genomische BCR-ABL1-Bruchpunkte bei kindlichen Leukämien
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms
Decrypting the role of HSP90α and β isoforms in BCR-ABL1+ leukemia and Characterization of Small Molecule HSP90 Inhibitors and Degraders
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K
The role of proteostasis in BCR-ABL1-positive acute lymphoblastic leukemia
Pre-B cell receptor signaling prevents malignant transformation by BCR-ABL1
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells
Genomische BCR-ABL1-Bruchpunkte bei kindlichen Leukämien
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms
Decrypting the role of HSP90α and β isoforms in BCR-ABL1+ leukemia and Characterization of Small Molecule HSP90 Inhibitors and Degraders
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K
The role of proteostasis in BCR-ABL1-positive acute lymphoblastic leukemia